Compare moats

Wide: the CUDA software platform and its developer installed base create high switching costs across the AI-training stack, defended by $76.7B cumulative R&D and reinforced by ~71% FY2026 gross margins and Data Center revenue (~90% of total) up 68% YoY — durable, hard-to-replicate advantages per the FY2026 10-K.

source: sec.gov

Axcelis's FY2025 10-K describes a protected but contested position. On the durable side, it says 'Axcelis and Applied Materials are the only ion implant system manufacturers with a full range of implant products'. About 3,400 Axcelis products are in use in 27 countries, and they feed an aftermarket business (CS&I) that earned $268.0 million, or 31.9% of 2025 revenue. The company holds 169 active U.S. patents and 356 active patents granted in other countries. On the limiting side, the risk factors say the ion implant segment 'includes one company with substantially greater financial, engineering, manufacturing, marketing and customer service and support resources', as well as 'several smaller companies that could provide innovative systems'. U.S. export controls 'exacerbate the risk that Chinese customers will change suppliers to non-U.S. vendors', while Kingstone Semiconductor and CETC 'continue to develop ion implanters for the Chinese domestic market'. 'None of our customers have entered into a long-term agreement requiring it to purchase our products.' Revenue fell to $839.0 million in 2025 from $1,017.9 million in 2024. A full-line position with a large installed base, against a better-resourced rival and new Chinese entrants, is a narrow moat.

source: sec.gov

Oracle's FY2026 10-K (fiscal year ended May 31, 2026) describes an installed base in which "substantially all customers opt to purchase software support contracts when they purchase an Oracle software license"; that entrenchment shows up externally as the #1 DB-Engines database ranking (August 2026, first of 435 systems) and $638B of contracted Remaining Performance Obligations at Q4 FY2026 (press release, June 10, 2026) — a durable, multi-decade lock on mission-critical enterprise data layers.

source: sec.gov

The durable edge rests on proprietary IP and software: the full-stack CUDA development platform running on all NVIDIA GPUs plus hundreds of proprietary domain libraries/SDKs/APIs, and $76.7B cumulative R&D yielding "inventions that are essential to modern computing" (NVIDIA invented the GPU in 1999). This is reinforced by developer-ecosystem network effects and CUDA switching costs, per the FY2026 10-K Business section.

source: sec.gov

The FY2025 10-K grounds the advantage in owned implant technology rather than contractual lock-in. Its Purion implanters share 'a common platform which enables a unique combination of implant purity, precision, and productivity', and its high energy systems use 'production-proven RF Linac high energy, spot beam technology'. System assembly and testing stays in-house 'due to the high degree of expertise and intellectual property associated with the process and design'. The company holds 169 active U.S. and 356 foreign patents, though it says it is not 'substantially dependent on any single patent or any group of patents'. The installed base supports aftermarket revenue but does not lock customers in: the risk factors say customers often train 'their own staff to maintain and service' equipment and buy parts that are not patent-protected from third parties. Switching costs are therefore the weaker candidate.

source: sec.gov

The core moat is the cost of moving mission-critical databases and back-office suites: the FY2026 10-K notes substantially all license customers attach support contracts and that Oracle's Multicloud Database offerings run Oracle AI Database inside other hyperscalers' clouds — monetizing the installed base even when the customer's infrastructure leaves; the KLAS 2026 EHR report shows the same dynamic in health IT, where roughly a third of Oracle Health customers want to leave but feel unable to do so.

source: sec.gov

FY2026 Data Center revenue was $193.7B (~90% of the $215.9B total), up 68% YoY on the Blackwell ramp, and NVIDIA describes itself as "a data center scale AI infrastructure company reshaping all industries." The 10-K frames named rivals as parties who "provide or intend to provide" GPUs/accelerators — incumbent-leader positioning.

source: sec.gov

The FY2025 10-K says 'In the market for ion implantation systems, we mainly compete against Applied Materials' and that the two 'are the only ion implant system manufacturers with a full range of implant products'. It claims Axcelis 'has been a market leader in high energy ion implanters for many years' and is 'a technology leader and supplier of choice' in power devices. But its risk factors say the implant segment includes 'one company with substantially greater' resources (unnamed there; Applied Materials is the main rival it names), and it lists 'Achieve market share leadership across all served markets' as a 2026 goal rather than a current fact. No third-party market-share source was fetched, so these are the company's own claims. Which of the two full-line suppliers has the larger overall share is not established by the sources read. Because the only basis for a shared lead is the company's own description, and that description treats share leadership as a goal not yet met, the band is held at fast_follower rather than co_leader.

source: sec.gov

Split by line: clear leader in database (DB-Engines August 2026 ranks Oracle #1 and Oracle-owned MySQL #2 of 435 systems); one of the largest enterprise-application vendors ($15.9B FY2026 SaaS revenue, competing with SAP, Salesforce, Workday and Microsoft per the FY2026 10-K); but in cloud infrastructure a ~4%-share fast-growing challenger behind Amazon (28%), Microsoft (20%) and Google (15%) per Synergy Q2 2026 data (The Register, 2026-08-01), and #2 in US acute-care EHR behind Epic (KLAS 2026).

source: sec.gov

FY2026 gross margin was 71.1% (75.0% in FY2025); per the 10-K MD&A the ~3.9pt decline reflects the Hopper HGX→Blackwell full-system mix shift and a one-time $4.5B H20 excess-inventory/purchase-obligation charge, not competitive price erosion. A low-70s% hardware gross margin evidences strong pricing power.

source: sec.gov

The FY2025 10-K reports gross margin of 44.9% in 2025 against 44.7% in 2024. That held steady while revenue fell from $1,017.9 million to $839.0 million, but its risk factors warn that 'if we must lower prices to remain competitive without commensurate cost of goods savings, our gross margin and profitability will be adversely affected'. They also say that if suppliers raise component costs, Axcelis 'may not be able to raise the price of our products to cover all or part of the increased cost'. On the Q2 2026 call (https://www.marketbeat.com/earnings/reports/2026-8-5-axcelis-technologies-inc-stock/), management reported a non-GAAP gross margin of 42.7% (the call states its income-statement measures are non-GAAP unless noted, so it is not directly comparable with the 10-K's GAAP figures), 'slightly below our outlook of 43%', citing CS&I mix and higher than anticipated services costs.

source: sec.gov

Strong in the installed base — the FY2026 10-K states substantially all license customers purchase support contracts, a recurring stream customers rarely drop — but the same 10-K lists "total cost of ownership" first among key competitive factors and describes intense competition across every segment; AI-infrastructure deals are won against hyperscalers and neoclouds, and Q4 FY2026 SaaS grew a moderate 10% versus 93% for IaaS (press release, June 10, 2026).

source: sec.gov

Upstream compute-platform supplier: NVIDIA sells full-stack data-center systems (GPU + Arm CPU + DPU + NVLink/InfiniBand networking + CUDA software) to cloud providers and enterprises, and relies on third-party foundry/assembly-test-packaging partners (e.g., SPIL, Amkor, Wistron, Fabrinet). Per the FY2026 10-K, several of its largest customers (hyperscalers such as Amazon, Alphabet, Microsoft) are simultaneously customers and emerging competitors developing internal accelerated-computing silicon.

A front-end wafer-fab equipment supplier to chipmakers, concentrated in Asia and in power devices. The FY2025 10-K says implanter shipments to Asian customers were 76.0% of 2025 system revenue, international sales 83.7% of total revenue, and the top ten customers 55.2% of net sales. It also says sales to Chinese customers are expected to remain significant under U.S. export-control licensing.

Supply-chain role in AI: OCI sells GPU compute for AI training and inference — the Q4 FY2026 press release attributes most of the $85B sequential RPO increase to large-scale AI contracts (some with customer-prepaid or customer-supplied GPUs totaling $75B) and guides FY2027 total revenue to $90B — making Oracle a primary capacity supplier to AI model builders.

• CUDA accelerated-computing software platform (CUDA-X, NVIDIA AI Enterprise) Leader · Deep source: sec.gov
• Data Center AI accelerators (GPU — Blackwell/Hopper) Leader · Deep source: sec.gov
• Data-center networking / interconnect (NVLink, InfiniBand, Spectrum Ethernet, DPUs) Top 3 · Moderate source: sec.gov

• CS&I aftermarket (spares, upgrades, used tools, services) Unknown · Moderate source: sec.gov
• High current and medium current implanters (Purion H, Dragon, H200, Purion M) Unknown · Moderate source: sec.gov
• High energy implanters (Purion XE/EXE, GSD Ovation batch) Top 3 · Moderate source: sec.gov
• Power device implanters (Purion Power Series) Top 3 · Moderate source: sec.gov

• Oracle AI Database (incl. Autonomous & Multicloud) Leader · Deep source: db-engines.com
• Oracle Cloud Applications (Fusion & NetSuite SaaS) Top 3 · Deep source: sec.gov
• Oracle Cloud Infrastructure (OCI) Challenger · Moderate source: theregister.com
• Oracle Health (Cerner) Top 3 · Moderate source: healthsystemcio.com

Editorial prior, not backtested.

see exactly how it voted →

Editorial prior, not backtested.

see exactly how it voted →

Editorial prior, not backtested.

see exactly how it voted →